67184-0540-1 : NDC 2026 Code

67184-0540-1 : Fosaprepitant Dimeglumine ( Fosaprepitant Dimeglumine )

Additionally :

You can get information about “67184-0540-1” NDC code in 67184-0540-1 in HTML format

HTML | 67184-0540-1 in TXT (Plain Text) format

TXT | 67184-0540-1 in PDF (Portable Document Format)

PDF | 67184-0540-1 in XML format

XML formats.

NDC Code : 67184-0540-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "67184-0540-1",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1)  / 5 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "67184-0540-01",
    "ProductNDC": "67184-0540",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Fosaprepitant Dimeglumine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Fosaprepitant Dimeglumine",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20200908",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA213106",
    "LabelerName": "Qilu Pharmaceutical Co., Ltd.",
    "SubstanceName": "FOSAPREPITANT DIMEGLUMINE",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-08-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20200908",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}